SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and ...
(PR-inside.com) Partnership unites the ReBalU Protocol, Vivos's sleep platform, and a new test for cells primed for chronic disease, reaching nearly 500,000 chronic‑disease patients VERO BEACH, FL / ACCESS Newswire / October 20, 2026 / SOD Sciences, Inc. ("SOD Sciences" or "SOD") today announced the closing of its stra…
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


